Sort
130,381 grants matching “hiv”
Integrating HIV Prevention into Clinical Care for PLWHA in South Africa
$1,377,153Jeffrey D Fisher · University Of Connecticut Storrs · R01 · FY2008 · MH
Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study
$1,377,055Linda A Teplin · Northwestern University At Chicago · R01 · FY2011 · DA
Units for HIV/AIDS Clinical Trials Networks
$1,376,949Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · U01 · FY2009 · AI
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$1,376,869Daniel Joseph Daltry · Vermont State Agency Of Human Services · U62 · FY2013 · PS
Positive Health Check Evaluation Trial
$1,376,652Megan A Lewis · Research Triangle Institute · U18 · FY2016 · PS
Clinical Research Support for the CCR
$1,376,369Thomas A Misteli · Division Of Basic Sciences - Nci · ZID · FY2016 · CA
Development of Dendrimer and Combination Microbicides
$1,376,160Starpharma, Ltd · U19 · FY2004 · AI
AFE inhibitor combinations as topical microbicides against HIV-1
$1,376,141John P Moore · Weill Medical Coll Of Cornell Univ · U19 · FY2006 · AI
HEALTH RELATED INTERVENTIONS FOR PERSONS LIVING WITH HIV
$1,376,099University Of California Los Angeles · R01 · FY2000 · MH
The National Drug Abuse Treatment Clinical Trials Network
$1,376,011Roger D. Weiss · Mclean Hospital · UG1 · FY2019 · DA
Early Life Vaccination to Prevent HIV acquisition during Adolescence
$1,375,878Sallie R. Permar · Weill Medical Coll Of Cornell Univ · P01 · FY2022 · AI
The East Coast AIDS and Cancer Specimen Resource
$1,375,741Sylvia Silver · George Washington University · U01 · FY2011 · CA
When are in-person HIV services worth the risk of COVID-19 and other communicable illnesses? Optimizing choices when virtual services are less effective
$1,375,435Anna Bershteyn · New York University School Of Medicine · RF1 · FY2025 · MH
Husbandry and Management Core
$1,375,358Charlotte Hotchkiss · University Of Washington · U42 · FY2023 · OD
Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk Men
$1,375,344Jeffrey T Parsons · Hunter College · UG3 · FY2017 · AI
HIV Prevention for Youth with Severe Mental Illness
$1,375,259Rhode Island Hospital · R01 · FY2004 · MH
The Bring BPaL2Me Trial - Comparing Nurse-Led RR-TB Treatment in Primary Care to Physician-Led, Hospital-Based RR-TB Treatment: A Cluster Randomized, Non-Inferiority Trial
$1,375,182Jason Edward Farley · Johns Hopkins University · R01 · FY2025 · AI
UCSF Prevention Research Center
$1,375,000Gregory Michael Rebchook · University Of California, San Francisco · U48 · FY2022 · DP
Pathogenesis Of Enteric Viral Hepatitis
$1,374,847Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Macque
$1,374,835Francois J Villinger · Emory University · U19 · FY2014 · AI
San Francisco Vaccine and Prevention Unit
$1,374,560Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2012 · AI
Molecular Mechanisms Of Human Immunodeficiency Virus Trans-regulatory Proteins
$1,374,378Kuan-Teh Jeang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Drugs of Abuse Affecting AIDS Pathogenesis
$1,374,325Thomas J Rogers · Temple Univ Of The Commonwealth · P01 · FY2011 · DA
Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease
$1,374,319Shenghan Lai · University Of Maryland Baltimore · U01 · FY2024 · DA
Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease
$1,374,319Shenghan Lai · University Of Maryland Baltimore · U01 · FY2023 · DA